Last updated: 15 September 2018 at 7:36am EST

Management Ltd Abg Ii So Lt... Net Worth




The estimated Net Worth of Management Ltd Abg Ii So Lt... is at least $1.5 Milhão dollars as of 12 September 2018. Management Lt owns over 297,568 units of Sorrento Therapeutics Inc stock worth over $10,130 and over the last 6 years Management sold SRNE stock worth over $1,493,791.

Management Lt SRNE stock SEC Form 4 insiders trading

Management has made over 1 trades of the Sorrento Therapeutics Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Management sold 297,568 units of SRNE stock worth $1,493,791 on 12 September 2018.

The largest trade Management's ever made was selling 297,568 units of Sorrento Therapeutics Inc stock on 12 September 2018 worth over $1,493,791. On average, Management trades about 297,568 units every 0 days since 2018. As of 12 September 2018 Management still owns at least 1,013,020 units of Sorrento Therapeutics Inc stock.

You can see the complete history of Management Lt stock trades at the bottom of the page.



What's Management Lt's mailing address?

Management's mailing address filed with the SEC is 3004 30th St #3002, Des Moines, IA 50310, USA.

Insiders trading at Sorrento Therapeutics Inc

Over the last 15 years, insiders at Sorrento Therapeutics Inc have traded over $17,198,839 worth of Sorrento Therapeutics Inc stock and bought 10,353,437 units worth $10,703,222 . The most active insiders traders include Jane Ph D Hsiao, Edgar Lee, ePatrick Chan Soon Shiong Fa.... On average, Sorrento Therapeutics Inc executives and independent directors trade stock every 60 days with the average trade being worth of $2,947. The most recent stock trade was executed by Henry Ji on 7 September 2022, trading 88,888 units of SRNE stock currently worth $179,554.



What does Sorrento Therapeutics Inc do?

sorrento therapeutics is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases. sorrento's lead products are multiple late-stage biosimilar and biobetter antibodies, as well as clinical car-t therapies targeting solid tumors.



What does Sorrento Therapeutics Inc's logo look like?

Sorrento Therapeutics Inc logo

Complete history of Management Lt stock trades at Sorrento Therapeutics Inc

Data
#
Companhia
Acionista maioritário
Trans.
Transação
Ações Preço por ação Preço total Ações após Fonte
12 Sep 2018 Management Ltd Abg Ii So Lt...
Venda 297,568 $5.02 $1,493,791
12 Sep 2018
1,013,020


Sorrento Therapeutics Inc executives and stock owners

Sorrento Therapeutics Inc executives and other stock owners filed with the SEC include: